Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) again finds itself in the news after a successful drug trial. The Henderson, Nevada-based biotech company achieved promising results in a phase 2 drug trial a few months after it …
Investors in Spectrum Pharmaceuticals, Inc. SPPI need to pay close attention to the stock based on moves in the options market lately. That is because the May 18 th 2018 $8.00 Put had some of the highest implied volatility of all equity …
Spectrum Pharmaceuticals (SPPI) revealed updated data from its Phase 2 study of ... higher Tuesday morning and is now up 3.15 at $17.78 on above average volume. The stock has jumped to nearly a 2-week high.
SPPI). All you have to do is sign up today for this free limited time offer by clicking the link below. …
Shares in Nevada headquartered Spectrum Pharmaceuticals Inc. ended the day 0.67% lower at $20.62. A total volume …
Analysts have very recently bumped up their estimates for SPPI, giving the stock a Zacks Earnings ESP of +14.29% heading into earnings season. Spectrum Pharmaceuticals, Inc. Price and EPS Surprise Spectrum Pharmaceuticals, …
Investors in Spectrum Pharmaceuticals, Inc. SPPI need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 20, 2018 $14 Call had some of the highest implied volatility of all equity options …